FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bruno Guerci

Research Profile

Disorders

Chemicals & Drugs

Devices

Procedures

Blood Glucose Self-Monitoring

Concepts & Ideas

Postprandial Period

Co-author Network

Publications

TOP 3
Martine Auclair; Franck Boccara; Jacqueline Capeau; Emilie Capel; Bruno Guerci; Olivier Lascols; Catherine Vigeral; Corinne Vigouroux; Martine Caron-Debarle
Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
Thomas Cuny; Bruno Guerci; Bertrand Cariou
New avenues for the pharmacological management of type 2 diabetes: an update.
Bruno Guerci; M-L Scherrer; C Bourgeois; Laurent Bresler; Philip Böhme
Gastric electrical stimulation for the treatment of diabetic gastroparesis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bruno Guerci (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Martine Auclair; Franck Boccara; Jacqueline Capeau; Emilie Capel; Bruno Guerci; Olivier Lascols; Catherine Vigeral; Corinne Vigouroux; Martine Caron-Debarle
Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
Arteriosclerosis, thrombosis, and vascular biology 2013;33(4):829-38.
2012: Thomas Cuny; Bruno Guerci; Bertrand Cariou
New avenues for the pharmacological management of type 2 diabetes: an update.
Annales d'endocrinologie 2012;73(5):459-68.
2012: Bruno Guerci; M-L Scherrer; C Bourgeois; Laurent Bresler; Philip Böhme
Gastric electrical stimulation for the treatment of diabetic gastroparesis.
Diabetes & metabolism 2012;38(5):393-402.
2012: Jean-Pierre Riveline; Claude Sachon; Pauline Schaepelynck; Agnès Sola-Gazagnes; Véronique Sulmont; Charles Thivolet; Nadia Tubiana-Rufi; Pierre-Yves Benhamou; Bogdan Catargi; Lucy Chaillous; Guillaume Charpentier; Bruno Guerci; Hélène Hanaire; Anne-Marie Leguerrier; Céline Lukas; Luc Millot; François Moreau; Alfred Penfornis; Régis P Radermecker; Eric Renard
Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study.
Diabetes care 2012;35(5):965-71.
2011: J-B Conart; Bruno Guerci; P Jonveaux; Toufic Maalouf; Karine Angioi
[Wolfram syndrome: clinical and genetic analysis in two sisters].
Journal français d'ophtalmologie 2011;34(8):543-6.
2011: Helene Hanaire; Monelle Bertrand; Bruno Guerci; Yves Anduze; Eric Guillaume; Patrick Ritz
High glycemic variability assessed by continuous glucose monitoring after surgical treatment of obesity by gastric bypass.
Diabetes technology & therapeutics 2011;13(6):625-30.
2010: L Stalnikiewicz; Michèle Floriot; Bruno Guerci; Karine Angioi
[Progression of diabetic retinopathy during pregnancy: a retrospective analysis of a series of 77 consecutive patients].
Journal français d'ophtalmologie 2010;33(7):481-6.
2008: Bruno Guerci; C Salaun Martin
Exenatide: its position in the treatment of type 2 diabetes.
Annales d'endocrinologie 2008;69(3):201-9.
2008: Christine Bellanné-Chantelot; Claire Carette; Jean-Pierre Riveline; René Valéro; Jean-François Gautier; Etienne Larger; Yves Reznik; Pierre-Henri Ducluzeau; Agnès Sola; Agnès Hartemann-Heurtier; Pierre Lecomte; Lucy Chaillous; Marie Laloi-Michelin; Jean-Marie Wilhem; Pierre Cuny; Françoise Duron; Bruno Guerci; Nathalie Jeandidier; Helen Mosnier-Pudar; Michel Assayag; Danièle Dubois-Laforgue; Gilberto Velho; José Timsit
The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3.
Diabetes 2008;57(2):503-8.
2007: Aurélie Decaudain; Marie-Christine Vantyghem; Bruno Guerci; Annie-Claude Hécart; Martine Auclair; Yves Reznik; Hervé Narbonne; Pierre-Henri Ducluzeau; Bruno Donadille; Céleste Lebbé; Véronique Béréziat; Jacqueline Capeau; Olivier Lascols; Corinne Vigouroux
New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.
The Journal of clinical endocrinology and metabolism 2007;92(12):4835-44.
2007: F Moreau; S Boullu-Sanchis; Corinne Vigouroux; C Lucescu; Olivier Lascols; Rémy Sapin; D Ruimy; Bruno Guerci; Michel Pinget; Nathalie Jeandidier
Efficacy of pioglitazone in familial partial lipodystrophy of the Dunnigan type: a case report.
Diabetes & metabolism 2007;33(5):385-9.
2007: Martine Caron; Martine Auclair; Bruno Donadille; Véronique Béréziat; Bruno Guerci; Martine Laville; H Narbonne; C Bodemer; Olivier Lascols; Jacqueline Capeau; Corinne Vigouroux
Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence.
Cell death and differentiation 2007;14(10):1759-67.
2007: Bruno Guerci
[Clinical results concerning glitazones].
Journées annuelles de diabétologie de l'Hôtel-Dieu 2007;():53-76.
2006: L Dufaitre-Patouraux; Jean-Pierre Riveline; Eric Renard; Vincent Melki; P Belicar-Schaepelynck; Jean-Louis Selam; Bruno Guerci; L Millot; Jean-Marcel Brun; C Fermon; B Catargi; H Gin; Nathalie Jeandidier; P J Lejeune; V Lassmann-Vague
Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative study.
Diabetes & metabolism 2006;32(5 Pt 1):427-32.
2005: Bruno Guerci; JP Sauvanet
Subcutaneous insulin: pharmacokinetic variability and glycemic variability.
Diabetes & metabolism 2005;31(4 Pt 2):4S7-4S24.
2005: Bruno Guerci; Nadia Tubiana-Rufi; B Bauduceau; R Bresson; A Cuperlier; C Delcroix; Danielle Durain; C Fermon; J P Le Floch; C Le Devehat; Vincent Melki; Louis Monnier; H Mosnier-Pudar; P Taboulet; Helene Hanaire-Broutin
Advantages to using capillary blood beta-hydroxybutyrate determination for the detection and treatment of diabetic ketosis.
Diabetes & metabolism 2005;31(4 Pt 1):401-6.
2005: Bruno Guerci
[Glitazones clinical data: an update].
Annales d'endocrinologie 2005;66(2 Pt 2):1S45-58.
2004: Pierre-Jean Guillausseau; Danièle Dubois-Laforgue; Pascale Massin; Marie Laloi-Michelin; Christine Bellanné-Chantelot; H Gin; E Bertin; JF Blickle; B Bauduceau; Beatrice Bouhanick; J Cahen-Varsaux; S Casanova; Guillaume Charpentier; P Chedin; C Derrien; A Grimaldi; Bruno Guerci; E Kaloustian; F Lorenzini; A Murat; F Olivier; Michel Paques; Véronique Paquis-Flucklinger; Amélie Tielmans; M Vincenot; Bernard Vialettes; José Timsit
Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (Maternally Inherited Diabetes and Deafness or MIDD).
Diabetes & metabolism 2004;30(2):181-6.
2004: Bruno Guerci
[Continuous glucose monitoring: which benefits?].
Annales d'endocrinologie 2004;65(1 Suppl):S59-67.
2003: H Gin; Eric Renard; Vincent Melki; S Boivin; P Schaepelynck-Bélicar; Bruno Guerci; Jean-Louis Selam; Jean-Marcel Brun; Jean-Pierre Riveline; B Estour; B Catargi
Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.
Diabetes & metabolism 2003;29(6):602-7.
2003: Bruno Guerci; Pierre Drouin; V Grangé; P Bougnères; P Fontaine; V Kerlan; Philippe Passa; Charles Thivolet; Bernard Vialettes; Bernard Charbonnel
Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.
Diabetes & metabolism 2003;29(6):587-94.
2003: Bruno Guerci
[Asymptomatic glycemic instability: how to measure it and which clinical applications? ].
Diabetes & metabolism 2003;29(2 Pt 1):179-88.
2003: Philip Böhme; Michèle Floriot; Marie-Aude Sirveaux; Danielle Durain; Olivier Ziegler; Pierre Drouin; Bruno Guerci
Evolution of analytical performance in portable glucose meters in the last decade.
Diabetes care 2003;26(4):1170-5.
2003: Bruno Guerci; Muriel Benichou; Michèle Floriot; Philip Böhme; Sebastien Fougnot; Patricia Franck; Pierre Drouin
Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients.
Diabetes care 2003;26(4):1137-41.
2003: Bruno Guerci; Michèle Floriot; Philip Böhme; Danielle Durain; Muriel Benichou; Stéphanie Jellimann; Pierre Drouin
Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs.
Diabetes care 2003;26(3):582-9.
2002: Laurent Meyer; Philip Böhme; Irène Delbachian; Philippe Lehert; Nathalie Cugnardey; Pierre Drouin; Bruno Guerci
The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients.
Diabetes care 2002;25(12):2153-8.
2001: Bruno Vergès; Bruno Guerci; Vincent Durlach; C Galland-Jos; Jean-Louis Paul; Laurent Lagrost; Philippe Gambert
Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects.
Journal of lipid research 2001;42(12):2021-9.
2001: Delphine Autran; Bruno Guerci; Jean-Louis Paul; Philippe Moulin; B Vergés; Vincent Durlach; anik girard-globa
Basal and postprandial serum-promoted cholesterol efflux in normolipidemic subjects: Importance of fat mass distribution.
Metabolism: clinical and experimental 2001;50(11):1330-5.
2001: Didier Quilliot; Evelyne Walters; Bruno Guerci; Jean-Charles Fruchart; Patrick Duriez; Pierre Drouin; Olivier Ziegler
Effect of the inflammation, chronic hyperglycemia, or malabsorption on the apolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitis.
Metabolism: clinical and experimental 2001;50(9):1019-24.
2001: Bruno Guerci; Jean-Louis Paul; Samy HADJADJ; Vincent Durlach; Bruno Vergès; Nebil ATTIA; anik girard-globa; Pierre Drouin
Analysis of the postprandial lipid metabolism: use of a 3-point test.
Diabetes & metabolism 2001;27(4 Pt 1):449-57.
2001: Bruno Guerci; Philip Böhme; Anna Kearney-Schwartz; Faiez Zannad; Pierre Drouin
Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
Diabetes & metabolism 2001;27(4 Pt 1):436-47.
2001: Bruno Guerci; Anna Kearney-Schwartz; Philip Böhme; Faiez Zannad; Pierre Drouin
Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function.
Diabetes & metabolism 2001;27(4 Pt 1):425-34.
2001: Olivier Ziegler; Didier Quilliot; Bruno Guerci; Pierre Drouin
[Macronutrients, fat mass, fatty acid flux and insulin sensitivity].
Diabetes & metabolism 2001;27(2 Pt 2):261-70.
2001: Didier Quilliot; Brigitte Dousset; Bruno Guerci; F Dubois; Pierre Drouin; Olivier Ziegler
Evidence that diabetes mellitus favors impaired metabolism of zinc, copper, and selenium in chronic pancreatitis.
Pancreas 2001;22(3):299-306.
2001: H Gin; Vincent Melki; Bruno Guerci; B Catargi
Clinical evaluation of a newly designed compliant side port catheter for an insulin implantable pump: the EVADIAC experience. Evaluation dans le Diabete du Traitement par Implants Actifs.
Diabetes care 2001;24(1):175.
2000: Bruno Guerci; Nathalie Jeandidier; V Lassmann-Vague; Eric Renard; Helene Hanaire-Broutin
[How should we use the short-acting insulin analog Lys-Pro in external continuous subcutaneous pumps?].
Diabetes & metabolism 2000;26(6):513-9.
2000: Olivier Ziegler; Didier Quilliot; Bruno Guerci
[Physiopathology of obesity. Dietary factors, and regulation of the energy balance].
Annales d'endocrinologie 2000;61 Suppl 6():12-23.
2000: Bruno Guerci; Samy HADJADJ; Didier Quilliot; Olivier Ziegler; Pierre Drouin
No acute response of leptin to an oral fat load in obese patients and during circadian rhythm in healthy controls.
European journal of endocrinology / European Federation of Endocrine Societies 2000;143(5):649-55.
2000: Corinne Vigouroux; Jocelyne Magré; Marie-Christine Vantyghem; C Bourut; Olivier Lascols; Sue Shackleton; David J Lloyd; Bruno Guerci; G Padova; P Valensi; A Grimaldi; R Piquemal; P Touraine; Richard C Trembath; Jacqueline Capeau
Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy.
Diabetes 2000;49(11):1958-62.
2000: Corinne Vigouroux; C Bourut; Bruno Guerci; Olivier Ziegler; Jocelyne Magré; Jacqueline Capeau; L Meyer
A new missense mutation in the calcium-sensing receptor in familial benign hypercalcaemia associated with partial lipoatrophy and insulin resistant diabetes.
Clinical endocrinology 2000;53(3):393-8.
2000: Bruno Guerci; Bruno Vergès; Vincent Durlach; Samy HADJADJ; Pierre Drouin; Jean-Louis Paul
Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patients.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(4):468-78.
2000: Pierre Drouin; Olivier Ziegler; Bruno Guerci
[Should one wait for a blood glucose meter?].
Journées annuelles de diabétologie de l'Hôtel-Dieu 2000;():211-25.
1999: Bruno Guerci; L Meyer; S Sommer; Jean Luc George; Olivier Ziegler; Pierre Drouin; K Angioï-Duprez
Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients.
Diabetes & metabolism 1999;25(5):412-8.
1999: Bruno Guerci; H Antebi; L Meyer; Vincent Durlach; Olivier Ziegler; J P Nicolas; LG Alcindor; Pierre Drouin
Increased ability of LDL from normolipidemic type 2 diabetic women to generate peroxides.
Clinical chemistry 1999;45(9):1439-48.
1999: Samy HADJADJ; Jean-Louis Paul; L Meyer; Vincent Durlach; Bruno Vergès; Olivier Ziegler; Pierre Drouin; Bruno Guerci
Delayed changes in postprandial lipid in young normolipidemic men after a nocturnal vitamin A oral fat load test.
The Journal of nutrition 1999;129(9):1649-55.
1999: Bruno Guerci; L Meyer; A Sallé; A Charrié; B Dousset; Olivier Ziegler; Pierre Drouin
Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients.
The Journal of clinical endocrinology and metabolism 1999;84(8):2673-8.
1999: L Meyer; Bruno Guerci; Olivier Ziegler; Pierre Drouin
[Insulin in the treatment of type 2 diabetes].
La Revue du praticien 1999;49(1):51-5.
1998: L Meyer; Samy HADJADJ; Bruno Guerci; Irène Delbachian; Olivier Ziegler; Pierre Drouin
Lipoatrophic diabetes mellitus treated by continuous subcutaneous insulin infusion.
Diabetes & metabolism 1998;24(6):544-6.
1998: Olivier Ziegler; Bruno Guerci; Pierre Drouin
[The "second atherogenic phenotype" or the role of insulin resistance in vascular risk].
Archives des maladies du coeur et des vaisseaux 1998;91 Spec No 5():33-9.
1998: Bruno Guerci; L Meyer; Irène Delbachian; M Kolopp; Olivier Ziegler; Pierre Drouin
Blood glucose control on Sunday in IDDM patients: intensified conventional insulin therapy versus continuous subcutaneous insulin infusion.
Diabetes research and clinical practice 1998;40(3):175-80.
1998: Vincent Melki; Eric Renard; V Lassmann-Vague; S Boivin; Bruno Guerci; Helene Hanaire-Broutin; J Bringer; P Belicar; Nathalie Jeandidier; L Meyer; P Blin; B Augendre-Ferrante; JP Tauber
Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.
Diabetes care 1998;21(6):977-82.
1997: V Lassmann-Vague; Bruno Guerci; Helene Hanaire-Broutin; Michel Pinget; Eric Renard; Jean-Louis Selam; Philippe Vague
Use of implantable insulin pumps: the EVADIAC position. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases). Evaluation dans le Diabete du Traitement par Implants Actifs.
Diabetes & metabolism 1997;23(3):234-50.
1997: Bruno Guerci; Danielle Durain; H Leblanc; J C Rouland; Philippe Passa; T Godeau; Bernard Charbonnel; J C Mathieu Daude; Hélène Boniface; Louis Monnier; F Dauchy; G Slama; Pierre Drouin
Multicentre evaluation of the DCA 2000 system for measuring glycated haemoglobin. DCA 2000 Study Group.
Diabetes & metabolism 1997;23(3):195-201.
1997: L Meyer; H Grulet; Bruno Guerci; A Gross; Vincent Durlach; M Leutenegger
Short-term intensive insulin therapy in insulin-requiring diabetes: effectiveness and factors predicting success.
Diabetes & metabolism 1997;23(1):75-9.
1996: Nathalie Jeandidier; J L Selam; Eric Renard; Bruno Guerci; V Lassman-Vague; L Rocher; Helene Hanaire-Broutin
Decreased severe hypoglycemia frequency during intraperitoneal insulin infusion using programmable implantable pumps. Evadiac Study Group.
Diabetes care 1996;19(7):780.
1996: Bruno Guerci; B Igau; Olivier Ziegler; T Crea; Jean-Charles Fruchart; Pierre Drouin; C Fievet
Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients.
Metabolism: clinical and experimental 1996;45(4):430-4.
1995: V Lassmann-Vague; Bruno Guerci; Helene Hanaire-Broutin; H Leblanc; Eric Renard; F Thervet; Philippe Vague
[Insulin pumps (portable pump for subcutaneous perfusion of insulin].
Diabète & métabolisme 1995;21(5):371-7.
1995: Olivier Ziegler; Bruno Guerci; H Candiloros; Pierre Drouin
[Lipoprotein (a) and diabetes mellitus].
Diabète & métabolisme 1995;21(2):127-38.
1995: Helene Hanaire-Broutin; C Broussolle; Nathalie Jeandidier; Eric Renard; Bruno Guerci; M J Haardt; V Lassmann-Vague
Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs.
Diabetes care 1995;18(3):388-92.
1994: Olivier Ziegler; H Candiloros; Bruno Guerci; I Got; T Crea; Pierre Drouin
Lower-extremity arterial disease in diabetes mellitus due to chronic pancreatitis.
Diabète & métabolisme 1994;20(6):540-5.
1994: Bruno Guerci; B Igau; Olivier Ziegler; T Crea; Jean-Charles Fruchart; Pierre Drouin; C Fievet
Lack of relationship between Lp(a) particle levels and albumin excretion rate in type 1 diabetic patients.
Diabète & métabolisme 1994;20(6):526-31.
1994: Olivier Ziegler; Bruno Guerci; M Algan; P Lonchamp; M Weber; Pierre Drouin
Improved visual evoked potential latencies in poorly controlled diabetic patients after short-term strict metabolic control.
Diabetes care 1994;17(10):1141-7.
1994: Olivier Ziegler; Bruno Guerci; S Muller; H Candiloros; L Méjean; M Donner; J F Stoltz; Pierre Drouin
Increased erythrocyte aggregation in insulin-dependent diabetes mellitus and its relationship to plasma factors: a multivariate analysis.
Metabolism: clinical and experimental 1994;43(9):1182-6.
1994: A P Guerci; Bruno Guerci; C Lévy-Marchal; J Ongagna; Olivier Ziegler; H Candiloros; O Guerci; Pierre Drouin
Onset of insulin-dependent diabetes mellitus after interferon-alfa therapy for hairy cell leukaemia.
Lancet 1994;343(8906):1167-8.
1994: Bruno Guerci; Olivier Ziegler; Pierre Drouin
[Hyperlipidemia during diabetes mellitus. Recent developments].
Presse médicale (Paris, France : 1983) 1994;23(2):82-8.
1993: Olivier Ziegler; Bruno Guerci; T Crea-Avila; H Candiloros; Pierre Drouin
[How I take charge and treat type II diabetes resistant to usual treatment].
Journées annuelles de diabétologie de l'Hôtel-Dieu 1993;():139-54.
1992: Olivier Ziegler; Bruno Guerci; P Drouin
[Blood glucose self-monitoring in 1993].
Diabète & métabolisme 1992;18(6):473-5.